Partners
Mannkind
Industry Partner
MannKind Corporation focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, IPF, PAH and NTM lung disease. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation.
FibroFind Bio
Expertise Partner
FibroFind is a rapidly developing biomedical sciences company with a deep understanding of fibrosis biology that has employed this knowledge to design bespoke human tissue assays. Our proprietary bioreactor cultured precision-cut tissue slices (PCTS) offer superior performance for biomarker identification, toxicology, target discovery and drug efficacy evaluation. Harnessing the power of robotics, AI-guided automated data analysis and a highly skilled technical team, FibroFind delivers unmatched technical quality in studies. Our current portfolio includes healthy and IPF-lung PCTS in 24, and 96 well formats, allowing us to tailor studies to best meet your investigative requirements.
Brainomix
Fortrea
Strados
Exhibition Partner
Ionis
Industry Partner
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.